Ameriprise Financial Inc BRIDGEBIO PHARMA INC Transaction History

Ameriprise Financial Inc

12,200,000

Previous 20,000,000 39.0%

Previous $0 NaN%

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	N/A	-7,800,000 Reduced 39.0%	12,200,000 $0
Q1 2025 May 14, 2025	SELL	N/A	-12,000,000 Reduced 37.5%	20,000,000 $0
Q4 2024 Feb 14, 2025	SELL	N/A	-500,000 Reduced 1.54%	32,000,000 $0
Q3 2024 Nov 14, 2024	BUY	N/A	9,500,000 Added 41.3%	32,500,000 $0
Q2 2024 Aug 14, 2024	SELL	N/A	-2,500,000 Reduced 9.8%	23,000,000 $0
Q4 2023 Feb 14, 2024	SELL	N/A	-3,500,000 Reduced 12.07%	25,500,000 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-3,200,000 Reduced 9.94%	29,000,000 $0
Q2 2023 Aug 14, 2023	SELL	N/A	-16,000,000 Reduced 33.2%	32,200,000 $0
Q1 2023 May 15, 2023	SELL	N/A	-178,000 Reduced 0.37%	48,200,000 $0
Q2 2022 Aug 15, 2022	SELL	N/A	-122,000 Reduced 0.25%	48,378,000 $19.8 Million
Q1 2022 May 16, 2022	BUY	N/A	48,500,000 New	48,500,000 $22.5 Million

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.